Pontifax Venture Capital
Overview
Pontifax is a healthcare-dedicated venture capital firm that seeks to invest in transformative, cutting-edge life sciences technologies at all development stages. The firm takes a hands-on approach with its portfolio companies. It also operates Pontifax AgTech, a fund focused on companies with proven technologies that improve the productivity, sustainability, and efficiency of the food and agriculture supply chain.
Portfolio Companies
25
Website
pontifax.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LB Pharmaceuticals | Sep 2025 | IPO | Co-investor |
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
| Graviton BioScience | May 2023 | Series A | Co-investor |
| Anaveon | Dec 2021 | Series B | Co-investor |
| Fore Biotherapeutics | Sep 2020 | Series C | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pontifax Venture Capital based?
Pontifax Venture Capital is headquartered in Herzliya, Tel Aviv District, Israel.
When was Pontifax Venture Capital founded?
Founding year information for Pontifax Venture Capital is not publicly available.
How many portfolio companies does Pontifax Venture Capital have?
Pontifax Venture Capital has 25 portfolio companies in Caplight's dataset.
What are some companies in Pontifax Venture Capital's portfolio?
Portfolio companies visible on Caplight include LB Pharmaceuticals, Crystalys Therapeutics, Graviton BioScience, Anaveon, Fore Biotherapeutics.
What was Pontifax Venture Capital's most recent investment shown here?
Pontifax Venture Capital's most recent investment in this portfolio sample was in Crystalys Therapeutics in 2026.
What sectors does Pontifax Venture Capital focus on?
Pontifax Venture Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Pontifax Venture Capital focus on?
Pontifax Venture Capital typically invests at the MultiStage stage.
What is Pontifax Venture Capital's AUM?
Pontifax Venture Capital's assets under management are estimated between $1.2B and $1.3B.